No Data
No Data
H.C. Wainwright Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $102
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Scotiabank Initiates Coverage On Viking Therapeutics With Sector Outperform Rating, Announces Price Target of $102
Institutional Investors May Adopt Severe Steps After Viking Therapeutics, Inc.'s (NASDAQ:VKTX) Latest 12% Drop Adds to a Year Losses
Scotiabank Initiates Viking Therapeutics(VKTX.US) With Buy Rating, Announces Target Price $102
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today